LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 57.18 | 84.90 | 666 | 6963 | 0.0956 | 0.3826 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 57.18 | 84.90 | 5928 | 6963 | 0.8513 | 0.9500 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 58.88 | 84.90 | 5 | 7291 | 0.0007 | -0.3565 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 58.88 | 84.90 | 3033 | 7291 | 0.4159 | 0.7447 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 58.88 | 84.90 | 693 | 7291 | 0.0950 | 0.3865 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 58.88 | 84.90 | 6293 | 7291 | 0.8630 | 0.9547 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 60.59 | 84.90 | 1 | 7641 | 0.0001 | -0.4955 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 60.59 | 84.90 | 3232 | 7641 | 0.4229 | 0.7517 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 60.59 | 84.90 | 773 | 7641 | 0.1012 | 0.4053 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 60.59 | 84.90 | 6536 | 7641 | 0.8553 | 0.9524 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 62.29 | 84.90 | 3 | 7934 | 0.0004 | -0.3999 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 62.29 | 84.90 | 3460 | 7934 | 0.4361 | 0.7619 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 62.29 | 84.90 | 768 | 7934 | 0.0968 | 0.3999 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 62.29 | 84.90 | 6849 | 7934 | 0.8632 | 0.9556 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 63.99 | 84.90 | 2 | 8212 | 0.0002 | -0.4335 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 63.99 | 84.90 | 3620 | 8212 | 0.4408 | 0.7664 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 63.99 | 84.90 | 788 | 8212 | 0.0960 | 0.4019 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 63.99 | 84.90 | 7063 | 8212 | 0.8601 | 0.9548 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 65.70 | 84.90 | 2 | 8484 | 0.0002 | -0.4312 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 65.70 | 84.90 | 3963 | 8484 | 0.4671 | 0.7835 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 65.70 | 84.90 | 860 | 8484 | 0.1014 | 0.4170 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 65.70 | 84.90 | 7378 | 8484 | 0.8696 | 0.9584 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 67.41 | 84.90 | 3 | 8766 | 0.0003 | -0.3933 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 67.41 | 84.90 | 4028 | 8766 | 0.4595 | 0.7805 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 67.41 | 84.90 | 880 | 8766 | 0.1004 | 0.4184 | MN20160318_Q02 | I20 |